Antonella Ingrosso

798 total citations
25 papers, 635 citations indexed

About

Antonella Ingrosso is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Antonella Ingrosso has authored 25 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 4 papers in Genetics. Recurrent topics in Antonella Ingrosso's work include Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Ferrocene Chemistry and Applications (3 papers). Antonella Ingrosso is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Ferrocene Chemistry and Applications (3 papers). Antonella Ingrosso collaborates with scholars based in Italy, United States and Czechia. Antonella Ingrosso's co-authors include Paul Bycott, Carla Soranzo, Sinil Kim, Ezra E.W. Cohen, Yazdi K. Pithavala, Francesco Paolo Cantatore, M Carrozzo, Michael A. Tortorici, S. Kim and Graziella Pratesi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Antonella Ingrosso

25 papers receiving 621 citations

Peers

Antonella Ingrosso
Gordon Moody United States
Brian Belmontes United States
J. M. G. Bonfrer Netherlands
R. Molife United Kingdom
Weili Sun United States
Antonella Ingrosso
Citations per year, relative to Antonella Ingrosso Antonella Ingrosso (= 1×) peers Valentina Tuninetti

Countries citing papers authored by Antonella Ingrosso

Since Specialization
Citations

This map shows the geographic impact of Antonella Ingrosso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonella Ingrosso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonella Ingrosso more than expected).

Fields of papers citing papers by Antonella Ingrosso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonella Ingrosso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonella Ingrosso. The network helps show where Antonella Ingrosso may publish in the future.

Co-authorship network of co-authors of Antonella Ingrosso

This figure shows the co-authorship network connecting the top 25 collaborators of Antonella Ingrosso. A scholar is included among the top collaborators of Antonella Ingrosso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonella Ingrosso. Antonella Ingrosso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ndou, Valentina, et al.. (2024). Framework for Agile Transformation: Guiding Organizations Through Cultural, Structural, and Competency Shifts in Project Management. Administrative Sciences. 14(11). 301–301. 2 indexed citations
2.
Generali, Luigi, Federica Veneri, Francesco Cavani, et al.. (2024). Quantitative Assessment of Apically Extruded Debris During Retreatment Procedures Using Three Nickel-Titanium Rotary Systems: An In Vitro Comparative Study. Dentistry Journal. 12(12). 384–384. 1 indexed citations
3.
Verschuur, Arnauld, Viera Bajčiová, Leo Mascarenhas, et al.. (2019). Sunitinib in pediatric patients with advanced gastrointestinal stromal tumor: results from a phase I/II trial. Cancer Chemotherapy and Pharmacology. 84(1). 41–50. 27 indexed citations
4.
Bondarenko, Igor, Antonella Ingrosso, Paul Bycott, Sinil Kim, & C. Cebotaru. (2015). Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non–small-cell lung cancer. BMC Cancer. 15(1). 339–339. 14 indexed citations
5.
Belani, Chandra P., Nobuyuki Yamamoto, Igor Bondarenko, et al.. (2014). Randomized phase II study of pemetrexed/cisplatin with or without axitinib for non-squamous non-small-cell lung cancer. BMC Cancer. 14(1). 290–290. 47 indexed citations
6.
Cohen, Ezra E.W., Michael A. Tortorici, S. Kim, et al.. (2014). A Phase II trial of axitinib in patients with various histologic subtypes of advanced thyroid cancer: long-term outcomes and pharmacokinetic/pharmacodynamic analyses. Cancer Chemotherapy and Pharmacology. 74(6). 1261–1270. 42 indexed citations
7.
Locati, Laura D., Lisa Licitra, Laura Agate, et al.. (2014). Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality‐of‐life assessments. Cancer. 120(17). 2694–2703. 86 indexed citations
8.
Verschuur, Arnauld, Jonathan C. Trent, Viera Bajčiová, et al.. (2014). A phase I/II study of sunitinib in young patients with advanced gastrointestinal stromal tumor.. Journal of Clinical Oncology. 32(15_suppl). TPS10601–TPS10601. 1 indexed citations
9.
Twelves, Chris, Ewa Chmielowska, Libor Havel, et al.. (2013). Randomised phase II study of axitinib or bevacizumab combined with paclitaxel/carboplatin as first-line therapy for patients with advanced non-small-cell lung cancer. Annals of Oncology. 25(1). 132–138. 30 indexed citations
10.
Rini, Brian I., Thibault De La Motte Rouge, Andrea Harzstark, et al.. (2013). Five-Year Survival in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma Treated With Axitinib. Clinical Genitourinary Cancer. 11(2). 107–114. 36 indexed citations
11.
Belani, Chandra P., Nobuyuki Yamamoto, Igor Bondarenko, et al.. (2012). A randomized phase II study of axitinib in combination with pemetrexed/cisplatin (pem/cis) as first-line therapy for nonsquamous non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 30(15_suppl). 7551–7551. 2 indexed citations
12.
Manegold, C., Nico van Zandwijk, A. Szczęsna, et al.. (2011). A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer. Annals of Oncology. 23(1). 72–77. 117 indexed citations
13.
Wolf, Daniel L., et al.. (2003). Pharmacokinetics and Renal Effects of Cidofovir with a Reduced Dose of Probenecid in HIV‐Infected Patients with Cytomegalovirus Retinitis. The Journal of Clinical Pharmacology. 43(1). 43–51. 37 indexed citations
14.
Maggiolo, Franco, et al.. (1997). Zidovudine and thymus humoral factor gamma-2 in the treatment of HIV infection: Preliminary clinical experience. Infection. 25(1). 35–38. 2 indexed citations
15.
Cantatore, Francesco Paolo, et al.. (1995). Effect of oestrogen replacement on bone metabolism and cytokines in surgical menopause. Clinical Rheumatology. 14(2). 157–160. 56 indexed citations
16.
Cantatore, Francesco Paolo, L. Mancini, Antonella Ingrosso, & M Carrozzo. (1995). Pachydermoperiostosis: Dermatological, neurological and radiological observations. Clinical Rheumatology. 14(6). 705–707. 17 indexed citations
17.
Soranzo, Carla, et al.. (1989). Changes in the three-dimensional organization of LoVo cells associated with resistance to doxorubicin. Cancer Letters. 48(1). 37–41. 3 indexed citations
18.
Soranzo, Carla, Gabriella Della Torre, & Antonella Ingrosso. (1986). Formation, Growth and Morphology of Multicellular Tumor Spheroids from a Human Colon Carcinoma Cell Line (LoVo). Tumori Journal. 72(5). 459–467. 16 indexed citations
19.
Aresta, Michele, et al.. (1981). Synthesis, chemical and biological properties of &{Pt[S(CH2)3Cl]2}6 and Pt[C6H3(oCH2CH CH2)(p-CH3)]2. Journal of Inorganic and Nuclear Chemistry. 43(6). 1415–1417. 4 indexed citations
20.
Aresta, Michele, et al.. (1979). Biological activity of metal complexes. I. Interaction of Pt(II), Pd(II) and Rh(I) complexes with E. coli strains and with mice LS fibroblasts in vitro. Chemico-Biological Interactions. 28(1). 61–70. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026